AMA applauds Surgeon General’s advisory on cannabis
AMA commends Surgeon General’s advisory on harmful health effects of cannabis use by pregnant women and youth, and commitment to furthering research on cannabis.
Physicians take steps against opioid epidemic, mortality rises
AMA opioids report highlights limited effects of mandates to stem an epidemic underscoring the need for focus on removing barriers to evidence-based treatment.
Doctors make progress on opioids, call on policymakers to do more
Opioid prescriptions fell by 33% over five years, says 2019 AMA Opioid Task Force report. Next step: Eliminate barriers to evidence-based treatment.
AMA Opioid Task Force recommendations offer roadmap to policymakers
The AMA Opioid Task Force recommendations call on policymakers to eliminate barriers to treatment and to take additional steps to end the opioid epidemic.
Patient Support & Advocacy
6 ways insurers drive the surprise-billing phenomenon
There is bipartisan support in Congress for action on so-called surprise billing—where patients unexpectedly receive a bill for care they thought their insurance covered.
AMA, NCMS, Manatt: Study of NC reversing opioid epidemic
A new report today by the AMA, North Carolina Medical Soc, and Manatt Health shows North Carolina is adopting strategies to combat the opioid epidemic.
Anyone can save a life with naloxone: What patients should know
The signs of an overdose, how to administer naloxone, and the toll of stigma covered by experts in a presentation at AMA’s Chicago headquarters.
Supreme Court looks to AMA for guidance in big health care cases
The AMA’s input has helped shape rulings on everything from alcoholism and transgender rights to medical privacy and the Affordable Care Act.
Pennsylvania removes prior authorization for opioid treatment
Pennsylvania and seven major health insurance companies agreed today to remove prior authorization requirements for treatment of substance use disorders.